Literature DB >> 19180113

Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy.

Pranela Rameshwar1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19180113      PMCID： PMC2835046          DOI： 10.1038/mt.2008.296

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

1.  Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens.

Authors:  Julius A Potian; Hana Aviv; Nicholas M Ponzio; Jonathan S Harrison; Pranela Rameshwar
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

2.  T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.

Authors:  Andrea Bacigalupo; Marisa Valle; Marina Podestà; Anna Pitto; Elena Zocchi; Antonio De Flora; Sara Pozzi; Silvia Luchetti; Francesco Frassoni; Maria Teresa Van Lint; Giovanna Piaggio
Journal:  Exp Hematol       Date:  2005-07       Impact factor: 3.084

3.  Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.

Authors:  Jennifer L Chan; Katherine C Tang; Anoop P Patel; Larissa M Bonilla; Nicola Pierobon; Nicholas M Ponzio; Pranela Rameshwar
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

4.  Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell.

Authors:  John Stagg; Sandra Pommey; Nicoletta Eliopoulos; Jacques Galipeau
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

5.  Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.

Authors:  Sarah Glennie; Inês Soeiro; Peter J Dyson; Eric W-F Lam; Francesco Dazzi
Journal:  Blood       Date:  2004-12-09       Impact factor: 22.113

Review 6.  Neurorestorative treatment of stroke: cell and pharmacological approaches.

Authors:  Jieli Chen; Michael Chopp
Journal:  NeuroRx       Date:  2006-10

Review 7.  Safety update on erythropoiesis-stimulating agents: trials within and outside the accepted indications.

Authors:  Pere Gascón
Journal:  Oncologist       Date:  2008

8.  Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells.

Authors:  Eugenia Flores-Figueroa; Juan José Montesinos; Patricia Flores-Guzmán; Guillermo Gutiérrez-Espíndola; Rosa María Arana-Trejo; Sebastián Castillo-Medina; Adrián Pérez-Cabrera; Erika Hernández-Estévez; Lourdes Arriaga; Hector Mayani
Journal:  Leuk Res       Date:  2008-04-10       Impact factor: 3.156

Review 9.  Plasticity and remodeling of brain.

Authors:  Michael Chopp; Yi Li; Jing Zhang
Journal:  J Neurol Sci       Date:  2007-07-03       Impact factor: 3.181

Review 10.  Aplastic anemia.

Authors:  Neal S Young; Phillip Scheinberg; Rodrigo T Calado
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284
View more
  9 in total

Review 1.  In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

Authors:  Yunching Chen; Dong-Yu Gao; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2014-05-22       Impact factor: 15.470

2.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 3.  Stem cells and regenerative medicine in lung biology and diseases.

Authors:  Allison N Lau; Meagan Goodwin; Carla F Kim; Daniel J Weiss
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

4.  Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.

Authors:  Raghavan Chinnadurai; Ian B Copland; Spencer Ng; Marco Garcia; Mahadev Prasad; Dalia Arafat; Greg Gibson; Subra Kugathasan; Jacques Galipeau
Journal:  Mol Ther       Date:  2015-04-22       Impact factor: 11.454

5.  Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity?

Authors:  S A Patel; C C King; P K Lim; U Habiba; M Dave; R Porecha; P Rameshwar
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

Review 6.  Stem cells and regenerative medicine: accomplishments to date and future promise.

Authors:  Karim Y Helmy; Shyam A Patel; Kimberly Silverio; Lillian Pliner; Pranela Rameshwar
Journal:  Ther Deliv       Date:  2010-11

7.  Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells.

Authors:  Shyam A Patel; Pranela Rameshwar
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09-01

8.  Directed induction of functional motor neuron-like cells from genetically engineered human mesenchymal stem cells.

Authors:  Hwan-Woo Park; Jung-Sun Cho; Chul-Kyu Park; Sung Jun Jung; Chang-Hwan Park; Shin-Jae Lee; Seog Bae Oh; Young-Seok Park; Mi-Sook Chang
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

9.  Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells.

Authors:  Ejlal Abu-El-Rub; Niketa Sareen; Weiang Yan; Keshav Narayan Alagarsamy; Alireza Rafieerad; Abhay Srivastava; Vincenzo Desiderio; Sanjiv Dhingra
Journal:  Cell Death Dis       Date:  2020-06-04       Impact factor: 8.469
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.